Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Simulations Plus, Inc.

< Previous 1 2 3 4 Next >
Simulations Plus to Present at Raymond James 44th Annual Institutional Investors Conference
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus and Global Agrochemicals Leader to Collaborate on Machine Learning Models
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Releases Redesigned NAFLDsym® QSP Software Tool
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Releases DILIsym X (DSX) Beta with Redesigned Software Infrastructure
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Executes $20 Million Accelerated Share Repurchase Agreement
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Reports First Quarter Fiscal 2023 Financial Results
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Sets Date for First Quarter Fiscal Year 2023 Earnings Release and Conference Call
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus and the University of Bath Awarded New FDA Grant
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Gustavo Mendes Lima Santos Joins the Simulations Plus Regulatory Fellowship Program
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus and the University of Florida Awarded New FDA Contract to Support Development and Regulatory Assessment of Inhaled Products
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Reports Fourth Quarter and Full Fiscal Year 2022 Financial Results
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Announces Cash Dividend
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Releases GastroPlus® Version 9.8.3
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Sets Date for Fourth Quarter and Fiscal Year 2022 Earnings Release and Conference Call
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus to Present at Sidoti Fall Small Cap Investor Conference
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Releases State-of-the-Art QSP Software for Interstitial Lung Disease
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Enters New Collaboration to Enhance Machine Learning Models for Ionization Constants (pKa)
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Presented New Scientific Developments at PAGE 2022
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Reports Third Quarter Fiscal 2022 Financial Results
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Hosts 2nd Annual Pharmacometrics Workshop
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Collaborates with Multinational Pharmaceutical Company to Provide Modeling & Simulation Support for COVID-19 Treatment
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Sets Date for Third Quarter Fiscal Year 2022 Earnings Release and Conference Call
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
DILIsym Software Publication Outlines Impact on the CGRP Field for Migraine
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Releases ADMET Predictor Version 10.4 (X.4)
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
U.S. FDA Renews Annual DILIsym Software Licenses for 2022
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Successfully Delivers FDA-Funded Project
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Enters New Collaboration to Advance DDDPlus™ Software
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus to Present at the Berenberg Discover AI Seminar
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Reports Second Quarter Fiscal 2022 Financial Results
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
Simulations Plus Receives $1.7 Million Grant for BIOLOGXsym™ Macromolecule Safety Software
From Simulations Plus, Inc.
Via Business Wire
Tickers SLP
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.